X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 51 filers reported holding X4 PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,890,957 | -49.6% | 8,156,841 | -10.3% | 0.00% | – |
Q2 2023 | $17,644,831 | +5803.0% | 9,095,274 | +2547.2% | 0.00% | – |
Q1 2023 | $298,914 | +9.6% | 343,580 | +25.1% | 0.00% | – |
Q4 2022 | $272,763 | -44.8% | 274,686 | -5.1% | 0.00% | – |
Q3 2022 | $494,000 | +84.3% | 289,383 | +4.3% | 0.00% | – |
Q2 2022 | $268,000 | -43.7% | 277,453 | +2.1% | 0.00% | – |
Q1 2022 | $476,000 | -24.2% | 271,794 | -1.0% | 0.00% | – |
Q4 2021 | $628,000 | -55.7% | 274,548 | +2.3% | 0.00% | – |
Q3 2021 | $1,419,000 | -17.1% | 268,450 | +2.0% | 0.00% | – |
Q2 2021 | $1,711,000 | -81.8% | 263,290 | -75.9% | 0.00% | – |
Q1 2021 | $9,399,000 | +41.4% | 1,091,753 | +5.6% | 0.00% | – |
Q4 2020 | $6,645,000 | -0.5% | 1,033,503 | +4.8% | 0.00% | – |
Q3 2020 | $6,677,000 | -26.4% | 986,193 | +1.4% | 0.00% | – |
Q2 2020 | $9,069,000 | +3.6% | 973,038 | +11.1% | 0.00% | – |
Q1 2020 | $8,755,000 | +2.3% | 875,549 | +9.5% | 0.00% | – |
Q4 2019 | $8,554,000 | -4.8% | 799,579 | +13.1% | 0.00% | – |
Q3 2019 | $8,984,000 | +31.2% | 706,907 | +54.9% | 0.00% | – |
Q2 2019 | $6,847,000 | +886.6% | 456,495 | +1044.8% | 0.00% | – |
Q1 2019 | $694,000 | – | 39,877 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 12,202,510 | $10,616 | 1.33% |
Tri Locum Partners LP | 3,878,484 | $3,374,281 | 1.03% |
Lynwood Capital Management Inc. | 900,000 | $783,000 | 0.71% |
NEA Management Company, LLC | 11,736,793 | $10,211,010 | 0.71% |
Parkman Healthcare Partners LLC | 2,797,147 | $2,433,518 | 0.53% |
SCOGGIN MANAGEMENT LP | 484,796 | $567,025 | 0.33% |
New Leaf Venture Partners, L.L.C. | 335,000 | $291,450 | 0.24% |
Ghost Tree Capital, LLC | 850,000 | $740,000 | 0.22% |
Perceptive Advisors | 4,545,454 | $3,954,545 | 0.12% |
Orbimed Advisors | 5,817,726 | $5,061,422 | 0.10% |